etodolac has been researched along with Choroid Neovascularization in 1 studies
Etodolac: A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE).
etodolac : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cyclooxygenases (COXs) are involved in choroidal neovascularization (CNV)." | 1.32 | COX-2-selective inhibitor, etodolac, suppresses choroidal neovascularization in a mice model. ( Muranaka, K; Takahashi, H; Tamaki, Y; Uchida, S; Yanagi, Y, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takahashi, H | 1 |
| Yanagi, Y | 1 |
| Tamaki, Y | 1 |
| Uchida, S | 1 |
| Muranaka, K | 1 |
1 other study available for etodolac and Choroid Neovascularization
| Article | Year |
|---|---|
COX-2-selective inhibitor, etodolac, suppresses choroidal neovascularization in a mice model.
Topics: Angiography; Animals; Choroidal Neovascularization; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; C | 2004 |